Dr. Tara LIN, MD
Claim this profileUniversity of Kansas Cancer Center
Studies Acute Myeloid Leukemia
Studies Leukemia
7 reported clinical trials
25 drugs studied
Affiliated Hospitals
Clinical Trials Tara LIN, MD is currently running
CYAD-02
for Leukemia/Preleukemia
This trial tests CYAD-02, a cell-based treatment, in patients with relapsed or refractory AML or MDS who haven't responded to standard treatments. Patients receive mild chemotherapy first, followed by CYAD-02 infusions to target cancer cells. If effective, they may receive additional doses.
Recruiting3 awards Phase 16 criteria
Targeted Therapies
for Acute Myeloid Leukemia
This screening and multi-sub-study Phase 1b/2 trial will establish a method for genomic screening followed by assigning and accruing simultaneously to a multi-study "Master Protocol (BAML-16-001-M1)." The specific subtype of acute myeloid leukemia will determine which sub-study, within this protocol, a participant will be assigned to evaluate investigational therapies or combinations with the ultimate goal of advancing new targeted therapies for approval. The study also includes a marker negative sub-study which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 1 & 24 criteria
More about Tara LIN, MD
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Tara LIN, MD has experience with
- Cytarabine
- Venetoclax
- Entospletinib
- Azacitidine
- Gilteritinib
- TP-0903
Breakdown of trials Tara LIN, MD has run
Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tara LIN, MD specialize in?
Tara LIN, MD focuses on Acute Myeloid Leukemia and Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved TP53 positive patients, or patients who are undergoing treatment.
Is Tara LIN, MD currently recruiting for clinical trials?
Yes, Tara LIN, MD is currently recruiting for 3 clinical trials in Fairway Kansas. If you're interested in participating, you should apply.
Are there any treatments that Tara LIN, MD has studied deeply?
Yes, Tara LIN, MD has studied treatments such as Cytarabine, Venetoclax, Entospletinib.
What is the best way to schedule an appointment with Tara LIN, MD?
Apply for one of the trials that Tara LIN, MD is conducting.
What is the office address of Tara LIN, MD?
The office of Tara LIN, MD is located at: University of Kansas Cancer Center, Fairway, Kansas 66205 United States. This is the address for their practice at the University of Kansas Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.